Thanks for the great summary points Aventurine.Much to look...

First 145 Last

Share
Profile

Follow
TonyIndo

11,332 Posts.

1452

26/11/19

20:44

Post #: 41647136
Share
Originally posted by aventurine: ↑

"They definitely have Aventurine, but I still have faith that the bigger picture (with a bit more time) could surprise".
Yes Tony, it seems like the baby may have got thrown out with the bath water.

So here is VOR having reached and/or on the cusp of:
8 consecutive quarters of positive operating cash flow
having delivered a tiny maiden profit in March, well on its way to another profit
expansion this year into Melbourne, Brisbane and London (I think they were already in Singapore)
being supported by macro tailwinds of 15-20% growth in cyber & cloud
with $2.8m cash in the bank (come December)
Sufficient cash to pay out C10
effectively debt free
cash flow to increase post the December quarter (last C10 payment in January 2020)
Just had our best quarter ever in terms of receipts ($4m with seasonal factors)
R&B on board and the influences/likes of Cadmon gone
SI's having just paid 0.011 to underwrite options
4 R&D projects in the pipeline, supported by internal cash flows
on the lookout for further acquisition(s)
having no individual contract considered to be material on revenue
seemingly enjoying a high client retention
being prepared to provide guidance for the forthcoming quarter
further accreditation for Protected Government accounts (federal, state & territories)
AWS clearing the path in relation to whole of Government deals

Yet somehow we find sentiment at a low and the SP is the same as in June, with tax loss selling.

Expand

Thanks for the great summary points Aventurine.

Much to look forward to, but for me, it's a potential acquisition that will improve not only their business strategy but also market sentiment. Let's see what transpires next year.

Tony
VOR Price at posting: 0.9¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 23 more messages in this thread...

First 145 Last

Add VOR (ASX) to my watchlist

Thanks for the great summary points Aventurine.Much to look...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News